Comanche secures $75M to test preeclampsia siRNA in PhII, adds Scott Gottlieb to board

Comanche Biopharma, an siRNA biotech created by veterans of The Medicines Company, has reeled in a $75 million Series B to test its drug candidate for preeclampsia, a pregnancy complication that impacts millions of women each year.

The Concord, MA-based biotech also said former FDA Commissioner Scott Gottlieb has joined…
Click here to view original post